AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

DG INNOVATE PLC

Report Publication Announcement Jun 4, 2018

4975_rns_2018-06-04_5d810054-3da5-4058-841e-f4d5274c7506.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2393Q

Path Investments plc

04 June 2018

Path Investments plc advises that the following replaces the Path Investments plc Availability of Annual Report and Notice of AGM announcement released at 14:13 BST on 4 June 2018 (under RNS Number 2232Q). The announcement should read as a General Meeting (GM) and not an Annual General Meeting (AGM) and has now been corrected.

All other details remain unchanged.

The full corrected version is shown below.

Path Investments plc

("Path" or the "Company")

Availability of Annual Report and Notice of GM

Path Investments plc (TIDM: PATH) announces that its Annual Report for the year ended 31 December 2017 will be available today on the Company's website at http://www.pathinvestmentsplc.com and that the Notice of General Meeting has been posted to shareholders.

The General Meeting will be held at 5 p.m. on 29 June 2018 at the offices of Womble Bond Dickinson (UK) LLP, 4 More London Riverside, London, SE1 2AU.

For further information please contact:

Path Investments plc

Christopher Theis

Andy Yeo
020 3934 6632
Shard Capital (Broker and Financial Adviser)

Simon Leathers

Damon Heath
020 7186 9900
IFC Advisory (Financial PR & IR)

Tim Metcalfe

Heather Armstrong

Miles Nolan
020 3934 6630

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCLLFFSRAISIIT

Talk to a Data Expert

Have a question? We'll get back to you promptly.